Here are the claims.
Claims
1. A method of treating insomnia, anxiety, or agitation in a subject in need of such therapy, comprising the step of administering to the subject pharmaceutically effective amount of a pharmaceutical selected from the group consisting of A2-73, A1-41 or A19-144.
2. The method of Claim 1 wherein said administering is selected from the group
consisting of oral administration, subcutaneous injection, intravenous injection, intraocular injection, intradermal injection, intramuscular injection, intraperitoneal injection, intratracheal administration, inhalation, intranasal administration, sublingual administration, buccal administration, rectal administration, vaginal administration, or topical administration.
3. The method of Claim 1 wherein said pharmaceutically effective amount is from about 10mg to about 100mg per day.
4. The method of Claim 3 wherein said pharmaceutically effective amount is from about 10mg to about 50mg per day.
5. The method of Claim 4 wherein said pharmaceutically effective amount is from about 20mg to about 30mg per day.
6. The method of Claim 1 wherein said pharmaceutical is A2-73.
7. The method of Claim 1 wherein said administering is daily.
8. The method of Claim 1 wherein said administration is for about 10 or more days out of 30 days.
9. The method of Claim 1 wherein said pharmaceutical is in an oral dosage form comprising a pharmaceutically acceptable carrier.
10. A method for treating insomnia, anxiety, or agitation in a subject in need of such therapy and further exhibiting systolic hypertension, comprising the step of administering to the subject pharmaceutically effective amount of a pharmaceutical selected from the group consisting of A2-73, A1 -41 or A19-144.
11. A method for treating insomnia, anxiety, or agitation in a subject exhibiting
symptoms of Alzheimer's disease and in need of such therapy, comprising the step of administering to the subject pharmaceutically effective amount of a
pharmaceutical selected from the group consisting of A2-73, A1-41 or A19-144.
"The refusal of the real is the number one dogma of our time" Rene Girard
